InsiderClue
Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score28
United States Fiscal year ends December CIK 0001356576
$42.67 +1.26% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $42.67 +50.14% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue215.0Operating income54.2Net income91.2EPS, diluted1.76Fiscal year 2017Revenue302.2 +40.6%Operating income99.5Net income57.3 −37.2%EPS, diluted1.08 −38.6%Fiscal year 2018Revenue408.9 +35.3%Operating income144.4Net income111.0 +93.8%EPS, diluted2.05 +89.8%Fiscal year 2019Revenue392.8 −3.9%Operating income148.6Net income113.1 +1.9%EPS, diluted2.10 +2.4%Fiscal year 2020Revenue520.4 +32.5%Operating income173.7Net income127.0 +12.3%EPS, diluted2.36 +12.4%Fiscal year 2021Revenue579.8 +11.4%Operating income86.0Net income53.4 −57.9%EPS, diluted0.98 −58.5%Fiscal year 2022Revenue667.2 +15.1%Operating income46.1Net income60.7 +13.6%EPS, diluted1.04 +6.1%Fiscal year 2023Revenue607.5 −8.9%Operating income−5.3Net income1.3 −97.8%EPS, diluted0.02 −98.1%Fiscal year 2024Revenue661.8 +8.9%Operating income81.7Net income73.9 +5,512.8%EPS, diluted1.32 +6,500.0%Fiscal year 2025Revenue719.0 +8.6%Operating income−62.3Net income−38.6 −152.2%EPS, diluted−0.68 −151.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 215.0 302.2 408.9 392.8 520.4 579.8 667.2 607.5 661.8 719.0
Growth +40.6% +35.3% −3.9% +32.5% +11.4% +15.1% −8.9% +8.9% +8.6%
Operating income 54.2 99.5 144.4 148.6 173.7 86.0 46.1 −5.3 81.7 −62.3
Net income 91.2 57.3 111.0 113.1 127.0 53.4 60.7 1.3 73.9 −38.6
Growth −37.2% +93.8% +1.9% +12.3% −57.9% +13.6% −97.8% +5,512.8% −152.2%
EPS, diluted 1.76 1.08 2.05 2.10 2.36 0.98 1.04 0.02 1.32 −0.68
Growth −38.6% +89.8% +2.4% +12.4% −58.5% +6.1% −98.1% +6,500.0% −151.5%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin25.2%Net margin42.4%Free cash flow margin30.3%Fiscal year 2017Operating margin32.9%Net margin19.0%Free cash flow margin37.3%Fiscal year 2018Operating margin35.3%Net margin27.1%Free cash flow margin31.3%Fiscal year 2019Operating margin37.8%Net margin28.8%Free cash flow margin35.7%Fiscal year 2020Operating margin33.4%Net margin24.4%Free cash flow margin25.9%Fiscal year 2021Operating margin14.8%Net margin9.2%Fiscal year 2022Operating margin6.9%Net margin9.1%Free cash flow margin17.4%Fiscal year 2023Operating margin−0.9%Net margin0.2%Free cash flow margin18.2%Fiscal year 2024Operating margin12.3%Net margin11.2%Free cash flow margin25.9%Fiscal year 2025Operating margin−8.7%Net margin−5.4%Free cash flow margin6.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 25.2% 32.9% 35.3% 37.8% 33.4% 14.8% 6.9% −0.9% 12.3% −8.7%
Net margin 42.4% 19.0% 27.1% 28.8% 24.4% 9.2% 9.1% 0.2% 11.2% −5.4%
Free cash flow margin 30.3% 37.3% 31.3% 35.7% 25.9% n/a 17.4% 18.2% 25.9% 6.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow66.8Capital expenditure−1.6Free cash flow65.2Fiscal year 2017Operating cash flow114.6Capital expenditure−2.0Free cash flow112.6 +72.7%Fiscal year 2018Operating cash flow129.0Capital expenditure−0.8Free cash flow128.1 +13.8%Fiscal year 2019Operating cash flow143.1Capital expenditure−2.7Free cash flow140.4 +9.6%Fiscal year 2020Operating cash flow138.4Capital expenditure−3.4Free cash flow135.0 −3.9%Fiscal year 2021Operating cash flow127.1Fiscal year 2022Operating cash flow116.8Capital expenditure−0.4Free cash flow116.4Fiscal year 2023Operating cash flow111.1Capital expenditure−0.6Free cash flow110.5 −5.1%Fiscal year 2024Operating cash flow172.0Capital expenditure−0.7Free cash flow171.2 +54.9%Fiscal year 2025Operating cash flow47.3Capital expenditure−1.3Free cash flow46.0 −73.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 66.8 114.6 129.0 143.1 138.4 127.1 116.8 111.1 172.0 47.3
Capital expenditure −1.6 −2.0 −0.8 −2.7 −3.4 n/a −0.4 −0.6 −0.7 −1.3
Free cash flow 65.2 112.6 128.1 140.4 135.0 n/a 116.4 110.5 171.2 46.0
Growth +72.7% +13.8% +9.6% −3.9% −5.1% +54.9% −73.1%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash66.4Shareholders’ equity191.8Fiscal year 2017Cash100.3Shareholders’ equity267.5Fiscal year 2018Cash192.2Shareholders’ equity453.0Fiscal year 2019Cash181.4Shareholders’ equity595.4Fiscal year 2020Cash288.6Shareholders’ equity744.9Fiscal year 2021Cash203.4Total debt379.3Net cash (debt)−175.8Shareholders’ equity815.9Debt to equity0.46Fiscal year 2022Cash93.1Shareholders’ equity886.2Fiscal year 2023Cash75.1Shareholders’ equity921.5Fiscal year 2024Cash69.3Shareholders’ equity1,035.7Fiscal year 2025Cash128.4Shareholders’ equity1,061.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 66.4 100.3 192.2 181.4 288.6 203.4 93.1 75.1 69.3 128.4
Total debt n/a n/a n/a n/a n/a 379.3 n/a n/a n/a n/a
Net cash (debt) n/a n/a n/a n/a n/a −175.8 n/a n/a n/a n/a
Shareholders’ equity 191.8 267.5 453.0 595.4 744.9 815.9 886.2 921.5 1,035.7 1,061.7
Debt to equity n/a n/a n/a n/a n/a 0.46 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
215.0 302.2 408.9 392.8 520.4 579.8 667.2 607.5 661.8 719.0
Growth +40.6% +35.3% −3.9% +32.5% +11.4% +15.1% −8.9% +8.9% +8.6%
12.0 15.2 15.4 16.7 52.5 n/a 87.2 83.8 77.9 74.6
42.8 49.6 89.2 69.1 76.0 90.5 74.6 91.6 108.8 106.2
106.0 137.9 154.7 153.2 200.7 304.8 377.2 336.4 321.6 485.6
54.2 99.5 144.4 148.6 173.7 86.0 46.1 −5.3 81.7 −62.3
Growth +83.6% +45.1% +2.9% +16.9% −50.5% −46.4% −111.4% −176.3%
50.4 100.6 140.2 147.5 168.6 73.2 60.7 2.8 97.9 −49.0
−40.9 43.3 29.2 34.4 41.7 19.8 0.0 1.5 24.0 −10.5
91.2 57.3 111.0 113.1 127.0 53.4 60.7 1.3 73.9 −38.6
Growth −37.2% +93.8% +1.9% +12.3% −57.9% +13.6% −97.8% +5,512.8% −152.2%
Per share
1.84 1.13 2.13 2.16 2.41 1.01 1.13 0.02 1.34 −0.68
1.76 1.08 2.05 2.10 2.36 0.98 1.04 0.02 1.32 −0.68
Growth −38.6% +89.8% +2.4% +12.4% −58.5% +6.1% −98.1% +6,500.0% −151.5%
49.5 50.8 52.0 52.4 52.6 53.1 53.7 54.5 55.1 56.5
51.7 53.3 54.1 53.8 53.7 54.4 61.7 55.5 56.0 56.5
Growth +3.1% +1.5% −0.5% −0.2% +1.2% +13.5% −10.0% +0.8% +0.9%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 6.7% a year over five years.
  • The diluted share count rose 5.1% in five years, which is dilution.
  • Operating margin is down 42.0 points on five years ago, at -8.7%.
  • A net loss in 1 of 10 years on file.